Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: June 2019

MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Files Patents for New DehydraTECH Innovation

Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) this morning announced that it has identified improved performance features of a new version of the DehydraTECH(TM) delivery platform primarily suitable for use in solid oral dosage … Continue reading

Posted in Lexaria Bioscience Corp. (LXRP), MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – Net Element, Inc. (NASDAQ: NETE) Launches Proprietary, AI-Powered Underwriting Solution with Predictive Scoring

Global technology and value-added solutions group Net Element (NASDAQ: NETE) today announced that it has launched Blade, its proprietary, fully-automated underwriting solution with predictive scoring powered by artificial intelligence (“AI”). Per the update, Blade is a software designed to reduce … Continue reading

Posted in MissionIRNewsBreaks, Net Element Inc. NETE | Leave a comment

INmune Bio Inc. (NASDAQ: INMB) to Offer Updates on Novel Immunotherapies During LD Micro Invitational

A presentation by INMB co-founder and CFO David Moss is slated for June 5 at 10:20 a.m., with one-on-one meetings also available The company’s active drug candidates are INKmune and INB03, which may be used to treat cancer, and XPro1595, … Continue reading

Posted in INmune Bio Inc. INMB | Leave a comment

MissionIRNewsBreaks – TransCanna Holdings Inc.’s (CSE: TCAN) (FSE: TH8) TCM Distribution Receives Adult Use Manufacturing and Distribution Permits from City of Adelanto

TransCanna Holdings (CSE: TCAN) (FSE: TH8) today announced that its wholly owned subsidiary, TCM Distribution, Inc., has received an adult use cannabis manufacturing permit and an adult use cannabis distribution permit from the City of Adelanto, California. According to the … Continue reading

Posted in MissionIRNewsBreaks, TransCanna Holdings Inc. TCAN | Leave a comment

Precision Therapeutics Inc. (NASDAQ: AIPT) Secures Lab Status in NIIMBL Drug Safety Grant, Furthers Aim of Improving Medical Care

The global precision medicine market is expected to reach revenues of over $216.75 billion by 2028, propelled by a growing interest in personalized approaches to disease treatments and the application of new technologies Precision Therapeutics and its three wholly owned … Continue reading

Posted in Precision Therapeutics Inc. AIPT | Leave a comment